Cambridge-based startup Mersana Therapeutics said today that it raised $75 million in an initial public offering. The company sold 5 million shares of common stock at $15 apiece. Mersana, which debuted on the Nasdaq exchange listed under “MRSN”, also gave underwriters a 30-day option to buy up to 750,000 more shares at $15 per share. […]
Ingen Technologies Inc.’s (OTC:IGNT) former CEO, Scott Sand, is headed to the slammer for his role in a plot involving the illegal manipulation of his company’s stock price.
The Yucaipa, Calif.-based medical device manufacturer named Tom Neavitt interim CEO to replace Sand and said current COO Gary Tilden will take over its day-to-day operations.